Migraine and Cluster Headache-Their Management with Sumatriptan: A Critical Review of The Current Clinical Experience
暂无分享,去创建一个
[1] G. Micieli,et al. Preemptive Oral Treatment With Sumatriptan During a Cluster Period , 1995, Headache.
[2] J. Jewsbury,et al. Long‐term Efficacy of Subcutaneous Sumatriptan Using a Novel Self‐injector , 1995, Headache.
[3] J. Mazziotta,et al. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. , 1994, The New England journal of medicine.
[4] J. Kay,et al. Sumatriptan in Acute Migraine Using a Novel Cartridge System Self‐Injector , 1994, Headache.
[5] G. Nappi,et al. Oral Sumatriptan: Effect of a Second Dose, and Incidence and Treatment of Headache Recurrences , 1994 .
[6] J. Olesen,et al. Subcutaneous sumatriptan during the migraine aura , 1994, Neurology.
[7] J. Olesen,et al. A Randomized Double-Blind Placebo-Controlled Crossover Study of Subcutaneous Sumatriptan in General Practice , 1994, Cephalalgia : an international journal of headache.
[8] J. Olesen,et al. 5-Hydroxytryptamine mechanisms in primary headaches , 1994 .
[9] C. Dahlöf,et al. Intranasal sumatriptan for the acute treatment of migraine , 1994, Journal of Neurology.
[10] J. Scanlon,et al. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. , 1994, The New England journal of medicine.
[11] D. K. Lloyd,et al. Long term use of sumatriptan , 1994, BMJ.
[12] J. Schoenen,et al. Self-Treatment of Acute Migraine with Subcutaneous Sumatriptan Using an Auto-Injector Device: Comparison With Customary Treatment in An Open, Longitudinal Study , 1994, Cephalalgia : an international journal of headache.
[13] M. Osborne,et al. Drug points: Is there a problem with long term use of sumatriptan in acute migraine? , 1994, BMJ.
[14] A. Panconesi,et al. Amplifying Effect of Sumatriptan on Noradrenaline Venoconstriction in Migraine Patients , 1993, Cephalalgia : an international journal of headache.
[15] O. Sjaastad,et al. Sumatriptan Relaxes Isolated Porcine Ophthalmic Artery, But Inhibits VIP-Induced Relaxation , 1993, Cephalalgia : an international journal of headache.
[16] K. Welch,et al. Drug therapy of migraine. , 1993, The New England journal of medicine.
[17] M. Solbach,et al. Treatment of Menstruation-Associated Migraine Headache With Subcutaneous Sumatriptan , 1993, Obstetrics and gynecology.
[18] M. Ferrari,et al. Lack of Asymmetry of Middle Cerebral Artery Blood Velocity in Unilateral Migraine , 1993, Stroke.
[19] J. Bouchet,et al. Subcutaneous Sumatriptan in the Acute Treatment of Migraine in Patients Using Dihydroergotamine as Prophylaxis , 1993, Headache.
[20] G. Renzenbrink,et al. 5-HT receptors mediating contractions of the isolated human coronary artery. , 1993, European journal of pharmacology.
[21] M. Bousser,et al. Efficacy of subcutaneous sumatriptan in the acute treatment of early‐morning migraine: a placebo‐controlled trial , 1993, Journal of internal medicine.
[22] K. Ekbom,et al. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study , 1993, Acta neurologica Scandinavica.
[23] M. Gross. THE USE OF SUMATRIPTAN IN THE TREATMENT OF MIGRAINE , 1993, The British journal of clinical practice.
[24] J. Osterhaus,et al. Efficacy of subcutaneous sumatriptan in repeated episodes of migraine , 1993, Neurology.
[25] H. Kaube,et al. Inhibition by sumatriptan of central trigeminal neurones only after blood‐brain barrier disruption , 1993, British journal of pharmacology.
[26] F. Rose,et al. Adverse reactions and sumatriptan , 1993, The Lancet.
[27] W. Hillis,et al. DRUG REACTIONS: Sumatriptan and chest pain , 1993 .
[28] A. Pilgrim,et al. The Safety of Sumatriptan in Asthmatic Migraineurs , 1993, Cephalalgia : an international journal of headache.
[29] M. Ferrari,et al. On Serotonin and Migraine: A Clinical and Pharmacological Review , 1993, Cephalalgia : an international journal of headache.
[30] D. Hoyer,et al. A proposed new nomenclature for 5-HT receptors. , 1993, Trends in pharmacological sciences.
[31] C. Dahlöf. Placebo-Controlled Clinical Trials with Ergotamine in the Acute Treatment of Migraine , 1993, Cephalalgia : an international journal of headache.
[32] M. Yacoub,et al. Sumatriptan and ischaemic heart disease , 1993, The Lancet.
[33] M. Maclean,et al. Adverse reactions associated with sumatriptan , 1993, The Lancet.
[34] J. Peacock,et al. Limitation of pulse oximetry , 1993, The Lancet.
[35] J. Ottervanger,et al. Transmural myocardial infarction with sumatriptan , 1993, The Lancet.
[36] T. Olsen,et al. Spreading Oligemia in the Migraine Aura-Most Likely an Artifact Due to Scattered Radiation , 1993, Cephalalgia : an international journal of headache.
[37] R. Lipton,et al. Migraine headache: Epidemiology and health care utilization , 1993, Cephalalgia : an international journal of headache.
[38] M. Moskowitz,et al. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[39] W. Hillis,et al. Effect of Subcutaneous Sumatriptan, a Selective 5HT1 Agonist, on the Systemic, Pulmonary, and Coronary Circulation , 1993, Circulation.
[40] S. Peroutka. 5‐Hydroxytryptamine Receptors , 1993, Journal of neurochemistry.
[41] H. Göbel,et al. Exteroceptive Suppression of Temporalis Muscle Activity: Perspectives in Headache and Pain Research , 1993, Cephalalgia : an international journal of headache.
[42] G. Sartory,et al. Contingent Negative Variation in Childhood Migraine , 1993, Cephalalgia : an international journal of headache.
[43] M. Tansey,et al. Sumatriptan in the acute treatment of migraine , 1993, Journal of the Neurological Sciences.
[44] P. Goadsby,et al. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats , 1993, Annals of neurology.
[45] B. Abrahamsen,et al. [Angina pectoris after sumatriptan (Imigran)]. , 1992, Ugeskrift for laeger.
[46] K. Preston,et al. Psychoactivity and abuse potential of sumatriptan , 1992, Clinical pharmacology and therapeutics.
[47] J. Saper,et al. Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group. , 1992, Archives of neurology.
[48] L. Houghton,et al. Effect of sumatriptan, a new selective 5HT1‐like agonist, on liquid gastric emptying in man , 1992, Alimentary pharmacology & therapeutics.
[49] D. Greitz,et al. MRI of Intracranial Arteries in Nitroglycerin Induced Cluster Headache Attacks , 1992, Headache.
[50] M. Ferrari,et al. Treatment of Migraine Attacks with Subcutaneous Sumatriptan: First Placebo-Controlled Study , 1992, Cephalalgia : an international journal of headache.
[51] A. Pilgrim,et al. Cardiorespiratory distress after sumatriptan given by injection , 1992 .
[52] W. Feniuk,et al. Migraine, Serotonin and Sumatriptan , 1992 .
[53] J. Olesen,et al. Sumatriptan is a Potent Vasoconstrictor of Human Dural Arteries Via a 5-HT1-Like Receptor , 1992, Cephalalgia : an international journal of headache.
[54] E. Waldenlind,et al. Sumatriptan in Chronic Cluster Headache: Results of Continuous Treatment for Eleven Months , 1992, Cephalalgia : an international journal of headache.
[55] M. Ferrari,et al. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks , 1992, Neurology.
[56] A. Pilgrim,et al. Coronary vasospasm and sumatriptan. , 1992, BMJ.
[57] L. Lacey,et al. Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers. , 1992, British journal of clinical pharmacology.
[58] R. Daroff. Cluster Headache Syndrome (Major Problems in Neurology, Vol. 23) , 1992, Neurology.
[59] M. Moskowitz,et al. CP‐93,129, sumatriptan, dihydroergotamine block c‐fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges , 1992, British journal of pharmacology.
[60] M. Moskowitz,et al. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. , 1992, Circulation research.
[61] N. Curzen,et al. Coronary vasospasm induced by subcutaneous sumatriptan. , 1992, BMJ.
[62] S. Clissold,et al. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. , 1992, Drugs.
[63] J. Edmeads. Migraine--disease or syndrome? , 1992, Pathologie-biologie.
[64] M. Ferrari. Biochemistry of migraine. , 1992, Pathologie-biologie.
[65] J. Olesen. Cerebral blood flow in migraine with aura. , 1992, Pathologie-biologie.
[66] L. Milne. Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group. , 1992, The New England journal of medicine.
[67] P. Fowler,et al. Lack of an interaction between propranolol and sumatriptan. , 1991, British journal of clinical pharmacology.
[68] W. Carter,et al. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion , 1991, Neuropharmacology.
[69] J. Lance,et al. Oral sumatriptan in acute migraine , 1991, The Lancet.
[70] J. Olesen,et al. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan , 1991, The Lancet.
[71] R. Tanner,et al. Preclinical studies on the anti-migraine drug, sumatriptan. , 1991, European neurology.
[72] J. Rothrock,et al. Treatment of acute migraine with subcutaneous sumatriptan. , 1991, JAMA.
[73] K. Merikangas. Comorbidity of Migraine and Other Conditions in the General Population of Adults in the United States , 1991 .
[74] L. Lacey,et al. Effect of Prophylactic Migraine Medications on the Pharmacokinetic and Pharmacodynamic Profiles of Sumatriptan , 1991 .
[75] N. Cutler,et al. Oral Sumatriptan in Pharmacokinetics in the Migrainous State , 1991 .
[76] J. Couch. Sumatriptan effective in therapy of acute migraine as demonstrated by four point pain and disability scales , 1991 .
[77] M. Moskowitz. The visceral organ brain , 1991, Neurology.
[78] P. Tfelt-Hansen. Guidelines for Controlled Trials of Drugs in Migraine. First Edition , 1991 .
[79] J. Heiligers,et al. Role of 5‐HT1‐like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan , 1991, British journal of pharmacology.
[80] E. Hamel,et al. Contractile 5‐HT1 receptors in human isolated pial arterioles: correlation with 5‐HT1D binding sites , 1991, British journal of pharmacology.
[81] T. Olsen,et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks , 1990, Annals of neurology.
[82] G. Martin,et al. 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. , 1990, Cardiovascular research.
[83] M. Skingle,et al. Lack of Antinociceptive Activity of Sumatriptan in Rodents , 1990, Cephalalgia : an international journal of headache.
[84] John M. Moran,et al. Neuromagnetic Fields in Migraine: Preliminary Findings , 1990, Cephalalgia : an international journal of headache.
[85] P. Goadsby,et al. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache , 1990, Annals of neurology.
[86] A. Sleight,et al. In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig , 1990, Neuropharmacology.
[87] K. Welch,et al. Migraine-related stroke in the context of the International Headache Society classification of head pain. , 1990, Archives of neurology.
[88] S. Hilal,et al. Focal headache during balloon inflation in the internal carotid and middle cerebral arteries. , 1990, Stroke.
[89] K. Spitzer,et al. Transcranial Doppler Evaluation of Common and Classic Migraine. Part II. Ultrasonic Features During Attacks , 1990, Headache.
[90] M. Lauritzen,et al. Ischemia May Be the Primary Cause of the Neurologic Deficits in Classic Migraine , 1990 .
[91] P. Leese,et al. Evaluation of the Safety and Pharmacokinetic Properties of Single Subcutaneous Doses of GR43175C in Healthy, Adult, Male Volunteers , 1989 .
[92] S. Levine,et al. 31P NMR Spectroscopy in Migraine , 1989 .
[93] A. Krabbe. Early Clinical Experience with Subcutaneous GR 43 175 in Acute Cluster Headache Attacks , 1989 .
[94] M. Ferrari,et al. Serotonin metabolism in migraine , 1989, Neurology.
[95] S. Peroutka,et al. Comparative Neuropharmacology of Dihydroergotamine and Sumatriptan (GR 43175) , 1989, Headache.
[96] P R Saxena,et al. 5-HT(1)-like receptor agonists and the pathophysiology of migraine. , 1989, Trends in pharmacological sciences.
[97] M. Perren,et al. The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175 , 1989, Cephalalgia : an international journal of headache.
[98] W. Feniuk,et al. 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. , 1989, European journal of pharmacology.
[99] W. Feniuk,et al. Characterization of 5‐HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5‐HT1‐like receptor agonist , 1989, British journal of pharmacology.
[100] M. Perren,et al. The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs , 1989, British journal of pharmacology.
[101] M. Moskowitz. Cluster Headache: Evidence for a Pathophysiologic Focus in the Superior Pericarotid Cavernous Sinus Plexus , 1988, Headache.
[102] A. Oxford,et al. GR43175, a selective agonist for the 5‐HT1‐like receptor in dog isolated saphenous vein , 1988, British journal of pharmacology.
[103] Giuseppe Orefice,et al. Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study , 1988, Cephalalgia : an international journal of headache.
[104] W. Stigelman,et al. Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .
[105] Jms Pearce. Headache. Diagnostic System and Taxonomic Criteria , 1986 .
[106] P. Kligfield,et al. Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias in mitral valve prolapse without mitral regurgitation. , 1985, The American journal of cardiology.
[107] M. Seybold,et al. Cluster headache. Local anesthetic abortive agents. , 1985, Archives of neurology.
[108] L. Fogan. Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. , 1985, Archives of neurology.
[109] M. Wilkinson. Treatment of the Acute Migraine Attack Current Status , 1983, Cephalalgia : an international journal of headache.
[110] F. Barre'. Cocaine as an Abortive Agent in Cluster Headache , 1982, Headache.
[111] L. Kudrow. Response of Cluster Headache Attacks to Oxygen Inhalation , 1981, Headache.
[112] C. Benedict,et al. Angina pectoris and sudden death in the absence of atherosclerosis following ergotamine therapy for migraine. , 1979, The American journal of medicine.
[113] T. Kallanranta,et al. Toxic Effects of Ergotamine Used for Migraine , 1978, Headache.
[114] H. L. Coysh,et al. Myocardial ischaemia in migraine sufferers taking ergotamine. , 1978, Postgraduate medical journal.
[115] A. Lieberman,et al. Cerebral Manifestations of Ergotism Report of a Case and Review of the Literature , 1976, Stroke.
[116] P. Andersson. ERGOTAMINE HEADACHE , 1975, Headache.
[117] J. Ochsner,et al. Peripheral ischemia secondary to ergotamine intoxication. , 1974, Archives of surgery.
[118] G. Volans,et al. Letter: Ergotamine-induced headaches. , 1974, British medical journal.
[119] Omel'chenko Na. Treatment of Migraine , 1955, The Lancet.
[120] H. Wolff,et al. EXPERIMENTAL STUDIES ON HEADACHE: PAIN-SENSITIVE STRUCTURES OF THE HEAD AND THEIR SIGNIFICANCE IN HEADACHE , 1940 .
[121] J. Dichgans,et al. Analgesic-induced chronic headache: long-term results of withdrawal therapy , 2004, Journal of Neurology.
[122] W. Bax,et al. Sumatriptan and ischaemic heart disease. , 1993, Lancet.
[123] M. Moskowitz,et al. SUMATRIPTAN: a receptor-targeted treatment for migraine. , 1993, Annual review of medicine.
[124] M. Tansey,et al. Long-term experience with sumatriptan in the treatment of migraine. , 1993, European neurology.
[125] M. Moskowitz,et al. SUMATRIPTAN: a receptor-targeted treatment for migraine. , 1993, Annual review of medicine.
[126] J. Askenasy,et al. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. , 1992, European neurology.
[127] R. Smith,et al. The safety and tolerability of sumatriptan: an overview. , 1991, European neurology.
[128] O. Keene,et al. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. , 1991, European neurology.
[129] J. Hannerz,et al. Treatment of acute cluster headache with sumatriptan , 1991 .
[130] J. Lance,et al. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group. , 1991, European neurology.
[131] J. Lance,et al. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group. , 1991, European neurology.
[132] J. Lance,et al. Sumatriptan An Oral Dose-Defining Study , 1991 .
[133] J. Lance,et al. A Placebo-Controlled Study of Intranasal Sumatriptan for the Acute Treatment of Migraine , 1991 .
[134] J. Lance,et al. A Randomized, Double-Blind Comparison of Sumatriptan and Cafergot in the Acute Treatment of Migraine , 1991 .
[135] M. Perren,et al. A rational approach to identifying a fundamentally new drug for the treatment of migraine , 1990 .
[136] P. Saxena,et al. Cardiovascular Pharmacology of 5-Hydroxytryptamine , 1990 .
[137] Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. , 1988, Cephalalgia : an international journal of headache.
[138] I. Husstedt,et al. Chronic ergotamine abuse: evidence of functional impairment of long ascending spinal tracts. , 1988, European neurology.
[139] P. Delwaide,et al. Topographic EEG mapping in common and classic migraine during and between attacks , 1987 .
[140] N. Lassen,et al. Ischemia may be the primary cause of the neurologic deficits in classic migraine. , 1987, Archives of neurology.
[141] G. Savoldi. Headache: Diagnostic System and Taxonomic Criteria , 1985 .
[142] J. Graham. Treatment of migraine. , 1955, The New England journal of medicine.